Neogen (NEOG) Officer Settles 35,736 RSUs Increasing Holdings

Rhea-AI Filing Summary

Neogen Corp (NEOG) officer John Edward Adent reported the vesting and settlement of restricted stock units into common stock on August 18, 2025. The filing shows 35,736 RSUs vested and were settled for 35,736 shares at an effective price of $5.43 per share, increasing his direct holdings to 307,012 shares following the transaction. The Form 4 was signed by an attorney-in-fact on August 20, 2025.

Positive

• Officer received equity compensation: 35,736 RSUs vested and were settled for 35,736 shares on 08/18/2025
• Increased direct ownership: Reporting person now beneficially owns 307,012 shares following the settlement
• Transparent disclosure: Transaction reported on Form 4 and signed by attorney-in-fact on 08/20/2025

Negative

• None.

Insights

Securities Analyst

TL;DR: Officer RSUs vested into 35,736 shares, raising direct holdings to 307,012 shares; routine insider reporting.

The transaction is a standard equity compensation settlement: 35,736 restricted stock units became common stock on 08/18/2025 at $5.43 per share. This increases the reporting officer's direct beneficial ownership to 307,012 shares. The Form 4 indicates no open-market purchase or sale; it documents compensation-related settlement activity requiring disclosure under Section 16.

Corporate Governance Expert

TL;DR: This is a routine insider disclosure of RSU vesting and settlement, not an unusual corporate event.

The filing records the conversion of RSUs into shares and conforms to Section 16 reporting requirements. It identifies the reporting person as the CEO and shows the filing was executed by an attorney-in-fact. No additional transactions, amendments, or derivative grants are reported beyond the settled RSUs.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ADENT JOHN EDWARD

(Last) (First) (Middle)

620 LESHER PLACE

(Street)

LANSING MI 48912

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/18/2025		M		35,736	A	$5.43	307,012	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$5.43	08/18/2025		M			35,736	08/18/2025	08/18/2025	Common Stock	35,736	$5.43	71,472	D

Explanation of Responses:

Remarks:

Each RSU is the economic equivalent of one share of common stock. On August 18, 2025, these RSUs vested and were settled for an equal number of shares of common stock.

	Christopher Sefcheck (Attorney in Fact)	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did NEOG insider John Edward Adent report on Form 4?

The Form 4 reports that 35,736 restricted stock units vested and were settled for 35,736 shares of Neogen common stock on 08/18/2025.

How many shares does the reporting person own after the transaction?

After the RSU settlement the reporting person beneficially owns 307,012 shares of Neogen common stock.

What price is shown on the Form 4 for the RSU settlement?

The filing lists a price of $5.43 per share associated with the RSU settlement.

What is the reporting person's role at NEOG?

The Form 4 identifies the reporting person as an Officer with the title CEO.

When was the Form 4 filed and who signed it?

The transaction date is 08/18/2025 and the Form 4 was signed by an attorney-in-fact, Christopher Sefcheck, on 08/20/2025.